» Articles » PMID: 37449005

The Association Between Visceral Adiposity Index and Chronic Kidney Disease in the Elderly: A Cross-sectional Analysis of NHANES 2011-2018

Overview
Journal Prev Med Rep
Date 2023 Jul 14
PMID 37449005
Authors
Affiliations
Soon will be listed here.
Abstract

Visceral adiposity index (VAI) is a new metric for evaluating visceral adiposity dysfunction. The aim of the present study was to explore the association between VAI and incident chronic kidney disease (CKD) in the American elderly population. We included 6085 participants aged 60 years or older with available data on renal function and VAI from the National Health and Nutrition Examination Survey (NHANES) from 2011 to 2018 and divided them into four groups according to the VAI quartiles. VAI values were ln-transformed to reduce skewness. We conducted multivariable logistic regression analyses and spline smoothing plot analyses to evaluate the association between VAI and CKD. After fully adjusting for confounding factors, higher lnVAI was associated with a higher risk of CKD (OR, 1.23; 95 %CI, 1.02, 1.48). Compared to the Q1 group (VAI < 1.1), The third and fourth VAI quartiles were associated with a higher prevalence of CKD (Q3: VAI, 1.8-3.0; Q4: VAI > 3.0). The adjusted ORs (95% CI) in Q3 and Q4 were 1.74 (1.24, 2.42) and 1.59 (1.08, 2.33). Adjusted smoothed plots suggested a nonlinear relationship between lnVAI and CKD. The development of CKD increased with increasing VAI among participants with a lnVAI between -0.6 and 1.6 (VAI: 0.5-5.0). In conclusion, VAI is significantly associated with the risk of CKD in the US elderly population aged 60 years or older.

Citing Articles

Investigating the role of the metabolic score for visceral Fat in assessing the prevalence of chronic kidney disease from the NHANES 1999-2018.

Zhou X, Xiang J, Zhang S, Yang J, Tang Y, Wang Y Sci Rep. 2025; 15(1):2397.

PMID: 39827188 PMC: 11742988. DOI: 10.1038/s41598-025-86723-3.


Association between visceral adiposity index and incidence of diabetic kidney disease in adults with diabetes in the United States.

Li C, Wang G, Zhang J, Jiang W, Wei S, Wang W Sci Rep. 2024; 14(1):17957.

PMID: 39095646 PMC: 11297263. DOI: 10.1038/s41598-024-69034-x.

References
1.
Chu N, Hong J, Harasemiw O, Chen X, Fowler K, Dasgupta I . Chronic kidney disease, physical activity and cognitive function in older adults-results from the National Health and Nutrition Examination Survey (2011-2014). Nephrol Dial Transplant. 2021; 37(11):2180-2189. PMC: 9585475. DOI: 10.1093/ndt/gfab338. View

2.
Mousapour P, Barzin M, Valizadeh M, Mahdavi M, Azizi F, Hosseinpanah F . Predictive performance of lipid accumulation product and visceral adiposity index for renal function decline in non-diabetic adults, an 8.6-year follow-up. Clin Exp Nephrol. 2019; 24(3):225-234. DOI: 10.1007/s10157-019-01813-7. View

3.
Hwang Y, Fujimoto W, Hayashi T, Kahn S, Leonetti D, Boyko E . Increased Visceral Adipose Tissue Is an Independent Predictor for Future Development of Atherogenic Dyslipidemia. J Clin Endocrinol Metab. 2015; 101(2):678-85. PMC: 4880131. DOI: 10.1210/jc.2015-3246. View

4.
Barbieri D, Goicoechea M, Sanchez-Nino M, Ortiz A, Verde E, Verdalles U . Obesity and chronic kidney disease progression-the role of a new adipocytokine: C1q/tumour necrosis factor-related protein-1. Clin Kidney J. 2019; 12(3):420-426. PMC: 6543966. DOI: 10.1093/ckj/sfy095. View

5.
Palmer B, Clegg D . The sexual dimorphism of obesity. Mol Cell Endocrinol. 2015; 402:113-9. PMC: 4326001. DOI: 10.1016/j.mce.2014.11.029. View